Becton Dickinson (BD) recently expanded its BD Cor system to include a new MX instrument for molecular testing of infectious diseases.
The new instrument and its first test for sexually transmitted infections have received the CE Mark for IVD directive 98/79/EC.
The first test available on the MX instrument is the BD CTGCTV2, which aims to use a single test to detect Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
The system assay was also included on the Australian Register for Therapeutic Goods following review by Australia's Medical Devices Regulator, the Therapeutic Goods Administration.
BD has expanded its BD Cor system to include a new MX instrument for high-throughput molecular testing for infectious diseases. Image courtesy of BD.
